Stock Updates

How has Abbott Laboratories:(NYSE:ABT) performed recently?

Abbott Laboratories (NYSE: ABT) is a large market cap stock with a market cap of 58265.97. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 27.76, a forward P/E of 16 and EPS of 1.42. At a stock price of 39.44 (-0.25%) it has a dividend yield of 2.64%.

EPS growth for the last five years have been -10.30%, more recently this last year it has grown by 53.50%. The next year growth is going to be about 11.89% and more long-term 9.40% after five years. EPS growth quarter over quarter is -89.20%. Sales growth for the past five years have been -10.30% and sales growth quarter over quarter is -0.20%.

For performance, Abbott Laboratories the past week has seen a gain of 6.74%. For the last month performance for Abbott Laboratories is 0.66%. While the last quarter is -5.61% and half year, -6.98%. Finally for the year, performance is -18.86%.

The 52-week high for Abbott Laboratories, is at -22.37%, and for the 52-week low it comes to a value of 10.22%. The 20-day simple moving average is 1.59% and -3.62% for the 200-day simple moving average.

Volatility for the week is at 1.55%, and for the month it is 1.45%. Abbott Laboratories, has a target price of 46.6.

In terms of debt, long term debt/equity is 0.29, and for total debt/equity Abbott Laboratories has 0.39. The gross margin is 56.90%, while operating margin is 13.60%, the profit margin is 12.00%. The current ratio is 1.5 and the quick ratio is 1.1.

Insider ownership is at 0.30%, with instituitional ownership at 70.80%. Abbott Laboratories has a payout ratio of 60.90%. With the total shares outstanding coming to 1477.33. The shares float is 1465.43, with the float short at 3.60%, with short ratio coming to 5.08.

In terms of returns, the return on assets see Abbott Laboratories, get 5.90%, with its returns on investment at 7.70%. Return on equity is 11.40%. So will the investors see the target price of 46.6, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment